Detalles de la búsqueda
1.
The utility of P-I-R classification in predicting the on-treatment histological and clinical outcomes of patients with hepatitis B and advanced liver fibrosis.
Hepatology
; 79(2): 425-437, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37611260
2.
Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related Events.
Clin Gastroenterol Hepatol
; 22(3): 591-601.e3, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38040276
3.
Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial.
Am J Gastroenterol
; 119(4): 700-711, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37929952
4.
A new glutamine synthetase index to evaluate hepatic lobular restoration in advanced fibrosis during anti-HBV therapy.
J Med Virol
; 95(2): e28555, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36738235
5.
Persistent steatosis correlates with decreased fibrosis regression during anti-HBV treatment in patients with chronic HBV infection.
J Med Virol
; 95(10): e29156, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37822064
6.
Two-year free of complications during antiviral therapy predicts stable re-compensation in immediate-treatment HBV-related decompensated cirrhosis.
Scand J Gastroenterol
; 58(4): 403-411, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36227688
7.
Comparative Performance of 14 HCC Prediction Models in CHB: A Dynamic Validation at Serial On-Treatment Timepoints.
Am J Gastroenterol
; 117(9): 1444-1453, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35973147
8.
Hepatocellular Carcinoma Prediction Models in Chronic Hepatitis B: A Systematic Review of 14 Models and External Validation.
Clin Gastroenterol Hepatol
; 19(12): 2499-2513, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33667678
9.
Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM.
Liver Int
; 41(2): 369-377, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33277803
10.
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy.
Clin Gastroenterol Hepatol
; 18(11): 2582-2591.e6, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32147592
11.
Dynamics of elastin in liver fibrosis: Accumulates late during progression and degrades slowly in regression.
J Cell Physiol
; 234(12): 22613-22622, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31102291
12.
Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients.
Mod Pathol
; 31(10): 1567-1577, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29785021
13.
New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment.
Hepatology
; 65(5): 1438-1450, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28027574
14.
Crosstalk of lysyl oxidase-like 1 and lysyl oxidase prolongs their half-lives and regulates liver fibrosis through Notch signal.
Hepatol Commun
; 8(4)2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38466882
15.
Liver fibrosis showed a two-phase regression rate during long-term anti-HBV therapy by three-time biopsies assessments.
Hepatol Int
; 18(3): 904-916, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38565833
16.
Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients.
Clin Mol Hepatol
; 29(3): 747-762, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37165622
17.
Recompensation in treatment-naïve HBV-related decompensated cirrhosis: a 5-year multi-center observational study comparing patients with ascites and bleeding.
Hepatol Int
; 17(6): 1368-1377, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37775724
18.
Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China.
J Clin Transl Hepatol
; 10(3): 420-428, 2022 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35836769
19.
Comparison of fibrosis regression of entecavir alone or combined with pegylated interferon alpha2a in patients with chronic hepatitis B.
Hepatol Int
; 15(3): 611-620, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33677771
20.
Health-related quality of life improves after entecavir treatment in patients with compensated HBV cirrhosis.
Hepatol Int
; 15(6): 1318-1327, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34843068